GE HealthCare Technologies Inc
For the period ended Sep 30, 2024. Filed Oct 30, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 30, 2024
GEHC$84.03+2.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Equity
| Condensed Consolidated Statements of Changes in Equity (Unaudited) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Common stock · Treasury stock | |||||||||
| (In millions) | Shares | Amount | Shares | Amount | Additional paid-in capital | Retained earnings | Accumulated other comprehensive income (loss) – net | Equity attributable to noncontrolling interests | Total equity |
| Balances as of June 30, 2024 | 457 | $5 | — | $— | $6,540 | $2,101 | $(845) | $16 | $7,817 |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | — | — | — | (25) | (10) | — | — | — | (35) |
| Net income attributable to GE HealthCare | — | — | — | — | — | 470 | — | — | 470 |
| Dividends declared ($0.03 per common share) | — | — | — | — | — | (14) | — | — | (14) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | 74 | — | 74 |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | 2 | 2 |
| Share-based compensation | — | — | — | — | 21 | — | — | — | 21 |
| Balances as of September 30, 2024 | 457 | $5 | — | $(25) | $6,551 | $2,558 | $(771) | $18 | $8,335 |
| Common stock | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In millions) | Shares | Amount | Additional paid-in capital | Retained earnings | Net parent investment | Accumulated other comprehensive income (loss) – net | Equity attributable to noncontrolling interests | Total equity |
| Balances as of June 30, 2023 | 455 | $5 | $6,451 | $576 | $— | $70 | $12 | $7,114 |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | — | — | (11) | — | — | — | — | (11) |
| Net income attributable to GE HealthCare | — | — | — | 375 | — | — | — | 375 |
| Dividends declared ($0.03 per common share) | — | — | — | (14) | — | — | — | (14) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | (350) | — | (350) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | (1) | (1) |
| Share-based compensation | — | — | 29 | — | — | — | — | 29 |
| Balances as of September 30, 2023 | 455 | $5 | $6,469 | $937 | $— | $(280) | $11 | $7,142 |
| Common stock · Treasury stock | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| (In millions) | Shares | Amount | Shares | Amount | Additional paid-in capital | Retained earnings | Accumulated other comprehensive income (loss) – net | Equity attributable to noncontrolling interests | Total equity |
| Balances as of December 31, 2023 | 455 | $5 | — | $— | $6,493 | $1,326 | $(691) | $12 | $7,145 |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | 2 | — | — | (25) | (34) | — | — | — | (59) |
| Net income attributable to GE HealthCare | — | — | — | — | — | 1,272 | — | — | 1,272 |
| Dividends declared ($0.09 per common share) | — | — | — | — | — | (41) | — | — | (41) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | (80) | — | (80) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | 6 | 6 |
| Share-based compensation | — | — | — | — | 92 | — | — | — | 92 |
| Balances as of September 30, 2024 | 457 | $5 | — | $(25) | $6,551 | $2,558 | $(771) | $18 | $8,335 |
| Common stock | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In millions) | Shares | Amount | Additional paid-in capital | Retained earnings | Net parent investment | Accumulated other comprehensive income (loss) – net | Equity attributable to noncontrolling interests | Total equity |
| Balances as of December 31, 2022 | — | $— | $— | $— | $11,235 | $(1,878) | $5 | $9,362 |
| Net transfers from GE, including Spin-Off-related adjustments | — | — | — | — | (4,842) | 2,000 | 2 | (2,840) |
| Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment | 454 | 5 | 6,388 | — | (6,393) | — | — | — |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | 1 | — | — | — | — | — | — | — |
| Net income attributable to GE HealthCare | — | — | — | 1,165 | — | — | — | 1,165 |
| Dividends declared ($0.09 per common share) | — | — | — | (41) | — | — | — | (41) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | (402) | — | (402) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | 4 | 4 |
| Share-based compensation | — | — | 81 | — | — | — | — | 81 |
| Changes in equity due to redemption value adjustments on redeemable noncontrolling interests | — | — | — | (187) | — | — | — | (187) |
| Balances as of September 30, 2023 | 455 | $5 | $6,469 | $937 | $— | $(280) | $11 | $7,142 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.